Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 25 of 41 entries
View as:

Study to Evaluate the Feasibility of [18F]Florbetapir PET for Assessment in MS Patients

Phase: N/A Priority: Normal
NCT ID: NCT01767493 Org: User:
Start: 11/30/12 End: 11/30/13 Due: 11/30/14

The Study of the Impact of Disclosing Imaging Study Information to Trial Participants

Phase: N/A Priority: Normal
NCT ID: NCT00354003 Org: User:
Start: 07/31/06 End: 08/31/08 Due: 08/31/09

A Study Evaluating Potential Screening Tools for Detecting Parkinson Disease

Phase: N/A Priority: Normal
NCT ID: NCT00387075 Org: User:
Start: 11/30/06 End: 08/31/23 Due: 08/31/24

Imaging and Genetic Biomarkers of Parkinson Disease (PD) Onset and Progression in High-risk Families

Phase: N/A Priority: Normal
NCT ID: NCT00273351 Org: User:
Start: 01/31/06 End: 01/31/08 Due: 01/31/09

Assessing Imaging as a Tool in Monitoring and Predicting the Progression of Parkinson Disease

Phase: N/A Priority: Normal
NCT ID: NCT00404170 Org: User:
Start: 11/30/06 End: 07/31/14 Due: 07/31/15

Evaluation of [123I] MNI-330 and SPECT as a Marker of Beta-amyloid Protein Deposition

Phase: N/A Priority: Normal
NCT ID: NCT00657813 Org: User:
Start: 03/31/08 End: 09/30/08 Due: 09/30/09

Evaluation of [123I] MNI-340 and SPECT as a Marker of Beta-Amyloid Protein Deposition

Phase: N/A Priority: Normal
NCT ID: NCT00968097 Org: User:
Start: 04/30/08 End: 07/31/08 Due: 07/31/09

Study of the Effects of Dopaminergic Medications on Dopamine Transporter Density in Subjects With Parkinson's Disease

Phase: N/A Priority: Normal
NCT ID: NCT00129181 Org: User:
Start: 01/31/05 End: 01/31/07 Due: 01/31/08

Evaluation of [18F] PBR111 and PET as a Marker of Inflammation in Subjects With Neurological Conditions

Phase: N/A Priority: Normal
NCT ID: NCT01209156 Org: User:
Start: 03/31/10 End: 06/30/13 Due: 06/30/14

Development of Imaging, Clinical and Biochemical Bio-Markers for Parkinson's Disease

Phase: N/A Priority: Normal
NCT ID: NCT00315250 Org: User:
Start: 01/31/06 End: 06/30/10 Due: 06/30/11

Biodistribution and Safety of a Radiopharmaceutical in Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT00316797 Org: User:
Start: 04/30/06 End: 01/31/14 Due: 01/31/15

Evaluation of [123I] AV151 and SPECT in Subjects w/ AD in Comparison to Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT00605046 Org: User:
Start: 08/31/07 End: 06/30/08 Due: 06/30/09

Evaluation of [123I] MNI-187 and SPECT in Patients With Alzheimers Disease in Comparison to Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT00456417 Org: User:
Start: 04/30/07 End: 12/31/07 Due: 12/31/08

Evaluation of [123I] AV94 and SPECT in Subjects With Alzheimer Disease in Comparison to Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT00605059 Org: User:
Start: 08/31/07 End: 06/30/08 Due: 06/30/09

A PET Brain Imaging Study of mGluR5 in Subjects With Neuropsychiatric Conditions

Phase: N/A Priority: Normal
NCT ID: NCT00870974 Org: User:
Start: 03/31/09 End: 11/30/16 Due: 11/30/17

Evaluation of 123-I Iodobenzovesamicol (IBVM) and SPECT Imaging of Healthy Subjects and Patients With Alzheimer Disease

Phase: N/A Priority: Normal
NCT ID: NCT00480701 Org: User:
Start: 02/28/07 End: 10/31/11 Due: 10/31/12

Safety and Efficacy of Positron Emission Tomography (PET) Imaging With MNI-558

Phase: N/A Priority: Normal
NCT ID: NCT01217021 Org: User:
Start: 09/30/10 End: 03/31/11 Due: 03/31/12

Development of Cognitive Assessment Tools in Parkinson Disease

Phase: N/A Priority: Normal
NCT ID: NCT00556764 Org: User:
Start: 07/31/07 End: 03/31/11 Due: 03/31/12

Evaluation of [123I] AV51 and SPECT as a Marker of Beta-amyloid Protein Deposition in Subjects With Alzheimer Disease in Comparison to Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT00556660 Org: User:
Start: 09/30/07 End: 07/31/08 Due: 07/31/09

Evaluation of [18F] PBR06 and PET as a Marker of Inflammation in Subjects With Neurological Conditions

Phase: N/A Priority: Normal
NCT ID: NCT01028209 Org: User:
Start: 11/30/09 End: 09/22/10 Due: 09/22/11

Single Photon Emission Computed Tomography (SPECT) Imaging Study to Develop a Biomarker for Alzheimer's Disease

Phase: N/A Priority: Normal
NCT ID: NCT00886951 Org: User:
Start: 03/31/09 End: 03/31/09 Due: 03/31/10

Research Involving Subjects With Parkinson's Disease, Alzheimer Disease and Healthy Controls

Phase: N/A Priority: Normal
NCT ID: NCT01461109 Org: User:
Start: 08/31/11 End: 05/31/14 Due: 05/31/15

Evaluation of [123I]CLINDE and SPECT as a Marker of Inflammation in Subjects With PD or AD and in Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT00612872 Org: User:
Start: 01/31/08 End: 11/01/09 Due: 11/01/10

Assess 123-I IMPY and SPECT Imaging as a Tool to Detect β-Amyloid in the Brain

Phase: N/A Priority: Normal
NCT ID: NCT00287248 Org: User:
Start: 02/28/06 End: 03/31/08 Due: 03/31/09

A Study of the Sense of Smell in Relatives of Parkinson's Disease Patients

Phase: N/A Priority: Normal
NCT ID: NCT00096876 Org: User:
Start: 10/31/04 End: 06/30/08 Due: 06/30/09